BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14657597)

  • 1. Changes in the activation and reconstitution of lymphocytes resulting from total-body irradiation correlate with slowed tumor growth.
    Miller GM; Kim DW; Andres ML; Green LM; Gridley DS
    Oncology; 2003; 65(3):229-41. PubMed ID: 14657597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose and timing of total-body irradiation mediate tumor progression and immunomodulation.
    Miller GM; Kajioka EH; Andres ML; Gridley DS
    Oncol Res; 2002; 13(1):9-18. PubMed ID: 12201676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cell depletion results in accelerated tumor growth and attenuates the antitumor effect of total body irradiation.
    Miller GM; Andres ML; Gridley DS
    Int J Oncol; 2003 Dec; 23(6):1585-92. PubMed ID: 14612930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation.
    Begovic M; Herberman R; Gorelik E
    Cancer Res; 1991 Oct; 51(19):5153-9. PubMed ID: 1913641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in efficacy of cancer radiotherapy by combination with whole-body low dose irradiation.
    Wu N; Jin SZ; Pan XN; Liu SZ
    Int J Radiat Biol; 2008 Mar; 84(3):201-10. PubMed ID: 18300020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic changes after loco-regional radiotherapy and fractionated total body irradiation (TBI) in mice.
    De Ruysscher D; Waer M; Vandeputte M; van der Schueren E
    Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1237-45. PubMed ID: 2532188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose and dose rate effects of whole-body gamma-irradiation: I. Lymphocytes and lymphoid organs.
    Pecaut MJ; Nelson GA; Gridley DS
    In Vivo; 2001; 15(3):195-208. PubMed ID: 11491014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow.
    Wiltrout RH; Pilaro AM; Gruys ME; Talmadge JE; Longo DL; Ortaldo JR; Reynolds CW
    J Immunol; 1989 Jul; 143(1):372-8. PubMed ID: 2732472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose gamma-rays activate immune functions via induction of glutathione and delay tumor growth.
    Kojima S; Nakayama K; Ishida H
    J Radiat Res; 2004 Mar; 45(1):33-9. PubMed ID: 15133287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic administration of recombinant interleukin-6 in mice induces proliferation of lymphoid cells in vivo.
    Puri RK; Leland P
    Lymphokine Cytokine Res; 1992 Jun; 11(3):133-9. PubMed ID: 1391232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of γδ T cells in α-galactosylceramide-mediated immunity.
    Paget C; Chow MT; Duret H; Mattarollo SR; Smyth MJ
    J Immunol; 2012 Apr; 188(8):3928-39. PubMed ID: 22412194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoattraction, adhesion and activation of natural killer cells are involved in the antitumor immune response induced by fractalkine/CX3CL1.
    Guo J; Chen T; Wang B; Zhang M; An H; Guo Z; Yu Y; Qin Z; Cao X
    Immunol Lett; 2003 Oct; 89(1):1-7. PubMed ID: 12946858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice with a targeted mutation in lymphotoxin-alpha exhibit enhanced tumor growth and metastasis: impaired NK cell development and recruitment.
    Ito D; Back TC; Shakhov AN; Wiltrout RH; Nedospasov SA
    J Immunol; 1999 Sep; 163(5):2809-15. PubMed ID: 10453025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total-body irradiation with high-LET particles: acute and chronic effects on the immune system.
    Gridley DS; Pecaut MJ; Nelson GA
    Am J Physiol Regul Integr Comp Physiol; 2002 Mar; 282(3):R677-88. PubMed ID: 11832386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG oligodeoxynucleotide 1826 enhances the Lewis lung cancer response to radiotherapy in murine tumor.
    Yuan S; Qiao T; Chen W
    Cancer Biother Radiopharm; 2011 Apr; 26(2):203-8. PubMed ID: 21539452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic expression of IL-33 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasis in mice.
    Gao K; Li X; Zhang L; Bai L; Dong W; Gao K; Shi G; Xia X; Wu L; Zhang L
    Cancer Lett; 2013 Jul; 335(2):463-71. PubMed ID: 23499895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The suppression of metastases and the change in host immune response after low-dose total-body irradiation in tumor-bearing rats.
    Hashimoto S; Shirato H; Hosokawa M; Nishioka T; Kuramitsu Y; Matushita K; Kobayashi M; Miyasaka K
    Radiat Res; 1999 Jun; 151(6):717-24. PubMed ID: 10360792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of natural killer function in lung, spleen, and peripheral blood lymphocytes: evidence of differential characteristics.
    Lauzon W; Yang H; Lemaire I
    Reg Immunol; 1990-1991; 3(3):145-50. PubMed ID: 2129104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
    J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.